<DOC>
	<DOCNO>NCT01087268</DOCNO>
	<brief_summary>RATIONALE : Radiation therapy cause long-term adverse effect . Hyperbaric oxygen therapy may effective lessen gastrointestinal symptom cause radiation therapy give pelvic cancer . It yet know whether high-pressure oxygen effective treat adverse effect cause radiation therapy . PURPOSE : This randomized phase III trial study hyperbaric oxygen therapy see well work treat long-term gastrointestinal adverse effect cause radiation therapy patient pelvic cancer .</brief_summary>
	<brief_title>Hyperbaric Oxygen Therapy Treating Long-Term Gastrointestinal Adverse Effects Caused Radiation Therapy Patients With Pelvic Cancer</brief_title>
	<detailed_description>OBJECTIVES : - To determine clinical benefit hyperbaric oxygen therapy reduce dysfunction patient pelvic cancer develop iatrogenic gastrointestinal symptom result previous radical pelvic radiotherapy complete least one year ago . OUTLINE : This multicenter study . Patients stratify accord center severity symptom ( low vs high ) . Patients randomize 1 2 treatment arm . - Arm I ( treatment group ) : Patients undergo hyperbaric oxygen therapy 90 minute , 5 day week , 8 week total 40 treatment . Oxygen 100 % breathe 30 minute , follow 5-minute `` air break '' 30 minute breathe oxygen . A 5-minute `` air break '' follow 30 minute breathe oxygen . During final 10 minute oxygen breathe , chamber depressurize ambient atmospheric pressure linear rate ( 14.2 kPa/min ) . - Arm II ( control group ) : Patients undergo hyperbaric oxygen therapy 90 minute , 5 day week , 8 week total 40 treatment . Oxygen 21 % breathe 30 minute , follow 5-minute `` air break '' 30 minute breathe oxygen . A 5-minute `` air break '' follow 30 minute breathe oxygen . During final 10 minute oxygen breathe , chamber depressurize ambient atmospheric pressure linear rate ( 3 kPa/min ) . Tissue sample rectal biopsy may collect analyzed . Patients complete questionnaire ( Health Economics , Inflammatory Bowel Disease Questionnaire [ IBDQ ] , EORTC Quality Life [ QLQ ] -C30 , QLQ-CR38 ) baseline 3 , 6 , 9 , 12 month start treatment . After completion study treatment , patient follow within 14 day 10 month .</detailed_description>
	<mesh_term>Prostatic Neoplasms</mesh_term>
	<mesh_term>Colorectal Neoplasms</mesh_term>
	<mesh_term>Sarcoma</mesh_term>
	<mesh_term>Urinary Bladder Neoplasms</mesh_term>
	<mesh_term>Uterine Cervical Neoplasms</mesh_term>
	<mesh_term>Neoplasms , Germ Cell Embryonal</mesh_term>
	<mesh_term>Endometrial Neoplasms</mesh_term>
	<mesh_term>Testicular Neoplasms</mesh_term>
	<mesh_term>Vaginal Neoplasms</mesh_term>
	<mesh_term>Radiation Injuries</mesh_term>
	<mesh_term>Pelvic Neoplasms</mesh_term>
	<criteria>DISEASE CHARACTERISTICS : Past history rectal , prostate , testicular , bladder , uterine cervix , uterine corpus , vaginal , ovarian cancer Malignant disease ( T13 , N01 , M0 ) No evidence cancer recurrence Gastrointestinal symptom attributable prior radiotherapy receive least 1 year ago , meet 1 follow criterion : Grade 2 high Late Effects Normal Tissues Subjective , Objective , Management , Analytic Scales ( LENT SOMA ) category Grade 1 difficult intermittent symptom Symptoms relieve appropriate lifestyle advice medication 3month period PATIENT CHARACTERISTICS : Must physically psychologically fit undergo hyperbaric oxygen therapy No claustrophobia No epilepsy No chronic obstructive airway disease , bullous lung disease , acute chronic pulmonary infection , uncontrolled asthma , untreated pneumothorax No previous middle/inner ear operation ( except grommet similar procedure ) and/or inability equalize middle ear pressure No contraindication inability undergo magnetic resonance imaging , require rule malignancy PRIOR CONCURRENT THERAPY : See Disease Characteristics No prior surgery rectal cancer No prior hyperbaric oxygen therapy ( exclude treatment decompression illness ) No prior treatment bleomycin</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>March 2010</verification_date>
	<keyword>gastrointestinal complication</keyword>
	<keyword>radiation toxicity</keyword>
	<keyword>long-term effect secondary cancer therapy adult</keyword>
	<keyword>stage I rectal cancer</keyword>
	<keyword>stage II rectal cancer</keyword>
	<keyword>stage III rectal cancer</keyword>
	<keyword>stage I prostate cancer</keyword>
	<keyword>stage IIB prostate cancer</keyword>
	<keyword>stage IIA prostate cancer</keyword>
	<keyword>stage III prostate cancer</keyword>
	<keyword>stage IV prostate cancer</keyword>
	<keyword>stage I bladder cancer</keyword>
	<keyword>stage II bladder cancer</keyword>
	<keyword>stage III bladder cancer</keyword>
	<keyword>stage IV bladder cancer</keyword>
	<keyword>stage IA cervical cancer</keyword>
	<keyword>stage IB cervical cancer</keyword>
	<keyword>stage IIA cervical cancer</keyword>
	<keyword>stage IIB cervical cancer</keyword>
	<keyword>stage III cervical cancer</keyword>
	<keyword>stage I vaginal cancer</keyword>
	<keyword>stage II vaginal cancer</keyword>
	<keyword>stage III vaginal cancer</keyword>
	<keyword>stage I malignant testicular germ cell tumor</keyword>
	<keyword>stage II malignant testicular germ cell tumor</keyword>
	<keyword>stage III malignant testicular germ cell tumor</keyword>
	<keyword>stage I endometrial carcinoma</keyword>
	<keyword>stage II endometrial carcinoma</keyword>
	<keyword>stage III endometrial carcinoma</keyword>
	<keyword>stage I uterine sarcoma</keyword>
	<keyword>stage II uterine sarcoma</keyword>
	<keyword>stage III uterine sarcoma</keyword>
	<keyword>stage IA ovarian epithelial cancer</keyword>
	<keyword>stage IB ovarian epithelial cancer</keyword>
	<keyword>stage IC ovarian epithelial cancer</keyword>
	<keyword>stage IIA ovarian epithelial cancer</keyword>
	<keyword>stage IIB ovarian epithelial cancer</keyword>
	<keyword>stage IIC ovarian epithelial cancer</keyword>
	<keyword>stage IIIA ovarian epithelial cancer</keyword>
	<keyword>stage IIIB ovarian epithelial cancer</keyword>
	<keyword>stage IIIC ovarian epithelial cancer</keyword>
	<keyword>stage IA ovarian germ cell tumor</keyword>
	<keyword>stage IB ovarian germ cell tumor</keyword>
	<keyword>stage IC ovarian germ cell tumor</keyword>
	<keyword>stage IIA ovarian germ cell tumor</keyword>
	<keyword>stage IIB ovarian germ cell tumor</keyword>
	<keyword>stage IIC ovarian germ cell tumor</keyword>
	<keyword>stage IIIA ovarian germ cell tumor</keyword>
	<keyword>stage IIIB ovarian germ cell tumor</keyword>
	<keyword>stage IIIC ovarian germ cell tumor</keyword>
</DOC>